Friday, May 8, 2015

(LML) Parenteral treatment of leprosy reactions

Leprosy Mailing List – May 8, 2015

Ref.:    (LML) Parenteral treatment of leprosy reactions    

From:  Hermanta Kumar Kar, New Delhi, India


 

 

Dear Pieter,

 

 

Referring to the recent discussions by Dr. Harun and Dr Jingquan in LML  regarding “Parenteral treatment of leprosy reactions” I want to add the following:

 

The evidence based research studies in the past, guide all of us to follow a standard guideline/protocol for management of leprosy reactions (T1R and T2R). Standard dose of prednisolone:1mg /kg body weight to start with gradual tapering of the dose to a minimal maintenance  dose for certain period of time(depending on several other factors) to prevent recurrence  is the key for management of reactions. High bullous dose of steroid is not desirable keeping in mind the possibility of occurrence adrenal crisis in many cases with chronic/recurrent ENL, one of the causes of death in leprosy. 

 

 

Regards,

 

 

Dr. Hemanta Kumar Kar
Professor in Dermatology, NDMC Medical College Delhi -110007
Former Director, Dean, Med. Superintendent and Professor(HOD) Dermatology
P.G.I.M.E.R. and Dr Ram Manohar Lohia Hospital
Baba Kharag Singh Marg
New Delhi-110001


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com




Avast logo

This email has been checked for viruses by Avast antivirus software.
www.avast.com


No comments: